Hikma Pharmaceuticals Plc Director/PDMR Shareholding (1627O)

TIDMHIK

RNS Number : 1627O

Hikma Pharmaceuticals Plc

15 May 2018

Hikma Pharmaceuticals PLC - EIP Vesting

LONDON, 15 May 2018: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 15 May 2015 under the 2014 Executive Incentive Plan ("EIP") Element C which was completed on 15 May 2018. These awards were automatically exercised by operation of the conditional award and vesting process. The exercise price under the EIP is GBPnil.

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  --------------------------------------------------------------- 
 a)   Name                   Said Darwazah 
---  ---------------------  ---------------------------------------- 
 2    Reason for the notification 
---  --------------------------------------------------------------- 
 a)   Position/status        Executive Chairman 
---  ---------------------  ---------------------------------------- 
 b)   Initial notification   Initial notification 
       /Amendment 
---  ---------------------  ---------------------------------------- 
 3    Details of the issuer, emission allowance market 
       participant, auction platform, auctioneer or 
       auction monitor 
---  --------------------------------------------------------------- 
 a)   Name                   Hikma Pharmaceuticals PLC 
---  ---------------------  ---------------------------------------- 
 b)   LEI                    549300BNS685UXH4JI75 
---  ---------------------  ---------------------------------------- 
 4    Details of the transaction(s): section to be 
       repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; 
       and (iv) each place where transactions have 
       been conducted 
---  --------------------------------------------------------------- 
 a)   Description            Description: Ordinary shares of 10 
       of the financial       pence each (Shares) 
       instrument,            ID Code: GB00B0LCW083 
       type of instrument 
       and identification 
       code 
---  ---------------------  ---------------------------------------- 
 b)   Nature of              Shares acquired from vesting of the 
       the transaction        conditional awards on 
                              15 May 2018 under the 2014 EIP Element 
                              C. 
---  ---------------------  ---------------------------------------- 
 c)   Price(s) and           Price(s): GBPnil 
       volume(s)              Volume(s): 27,000 
---  ---------------------  ---------------------------------------- 
 d)   Aggregated             N/A 
       information 
---  ---------------------  ---------------------------------------- 
 e)   Date of the            15 May 2018 
       transaction 
---  ---------------------  ---------------------------------------- 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
---  ---------------------  ---------------------------------------- 
 

Mazen Darwazah

 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  --------------------------------------------------------------- 
 a)   Name                   Mazen Darwazah 
---  ---------------------  ---------------------------------------- 
 2    Reason for the notification 
---  --------------------------------------------------------------- 
 a)   Position/status        Executive Vice Chairman 
---  ---------------------  ---------------------------------------- 
 b)   Initial notification   Initial notification 
       /Amendment 
---  ---------------------  ---------------------------------------- 
 3    Details of the issuer, emission allowance market 
       participant, auction platform, auctioneer or 
       auction monitor 
---  --------------------------------------------------------------- 
 a)   Name                   Hikma Pharmaceuticals PLC 
---  ---------------------  ---------------------------------------- 
 b)   LEI                    549300BNS685UXH4JI75 
---  ---------------------  ---------------------------------------- 
 4    Details of the transaction(s): section to be 
       repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; 
       and (iv) each place where transactions have 
       been conducted 
---  --------------------------------------------------------------- 
 a)   Description            Description: Ordinary shares of 10 
       of the financial       pence each (Shares) 
       instrument,            ID Code: GB00B0LCW083 
       type of instrument 
       and identification 
       code 
---  ---------------------  ---------------------------------------- 
 b)   Nature of              Shares acquired from vesting of the 
       the transaction        conditional awards on 
                              15 May 2018 under the 2014 EIP Element 
                              C. 
---  ---------------------  ---------------------------------------- 
 c)   Price(s) and           Price(s): GBPnil 
       volume(s)              Volume(s): 20,000 
---  ---------------------  ---------------------------------------- 
 d)   Aggregated             N/A 
       information 
---  ---------------------  ---------------------------------------- 
 e)   Date of the            15 May 2018 
       transaction 
---  ---------------------  ---------------------------------------- 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
---  ---------------------  ---------------------------------------- 
 

Peter Speirs

Company Secretary, responsible for releasing this announcement

[phone]

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBXGDUDDBBGIU

(END) Dow Jones Newswires

May 15, 2018 09:26 ET (13:26 GMT)